Skip to main content
. 2010 Oct 14;2(10):678–690. doi: 10.18632/aging.100208

Table 2. Summary of putative C. elegans O-GlcNAc targets.

Proteins Molecular Identity Expression in daf-2 mutant O-GlcNAc modified in vertebrate homologs
PHI-37 F0F1-type ATP synthase Downregulated [46] NR
ATP-2 F0F1-type ATP synthase Downregulated [46] NR
MDH-1 Malate dehydrogenase Downregulated [47] MDH1 [7]
GPD-2, GPD-3 Glyceraldehyde-3-phosphate dehydrogenase, major isozyme Upregulated [48,49] GAPDH [7,50]
GPD-1, GPD-4 Glyceraldehyde-3-phosphate dehydrogenase, minor isozyme Downregulated [46] GAPDH [7,50]
EFT-3, EFT-4 Translation elongation factor 1 alpha Downregulated [46] EEF1AO [50]
ACT-1, ACT-2, ACT-3, ACT-4 Actin Downregulated [46] ACTG1 [7]
TBA-1, TBA-2, TBA-4 Alpha tubulin Downregulated [46] TUBA1A [7]
VIT-6 Vitellogenin Downregulated [46] NR
VHA-13 Vacuolar protein translocating ATPase NR NR
CDC-48.2 AAA-type ATPase NR NR
F27D4.1 Electron transfer flavoprotein NR NR
C16A3.10 Ornithine aminotransferase Downregulated [48] NR

EFT-3 and EFT-4 have identical protein sequences, as do GPD-2 and GPD-3. The peptides identified by LC-MS/MS did not distinguish between the almost identical ACT-1, ACT-2, ACT-3, and ACT-4; TBA-1, TBA-2, and TBA-4; or GPD-2 and GPD-3, respectively. NR, not reported.